Shrink cancer therapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Neoplastic Stem Cells Microtubules Cell Line HeLa Cells Hep G2 Cells

Organisms6

Mice, Nude Mice, Inbred BALB C Mice, SCID Cattle Mice, Inbred C57BL Adenoviridae

Diseases42

Neoplasms Radiation Injuries Breast Neoplasms Pasteurellosis, Pneumonic Colonic Neoplasms Lung Neoplasms Prostatic Neoplasms Ovarian Neoplasms Neoplasms, Radiation-Induced Neoplasm Metastasis Pancreatic Neoplasms Stomach Neoplasms Neoplasm Invasiveness Radiation Injuries, Experimental Carcinoma, Squamous Cell Pasteurella Infections Radiation Pneumonitis Neoplasms, Experimental Neovascularization, Pathologic Carcinoma, Non-Small-Cell Lung Carcinoma Adenocarcinoma Cell Transformation, Neoplastic Uterine Cervical Neoplasms Head and Neck Neoplasms Colorectal Neoplasms Disease Progression Liver Neoplasms Brain Neoplasms Urinary Bladder Neoplasms Neoplasm Recurrence, Local Melanoma Mammary Neoplasms, Experimental Cattle Diseases Genetic Predisposition to Disease Skin Neoplasms Rectal Neoplasms Acute Radiation Syndrome Disease Models, Animal Bone Neoplasms Glioblastoma Glioma

Chemicals and Drugs79

Antineoplastic Agents Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin Antibiotics, Antineoplastic Drug Carriers Neoplasm Proteins Tumor Suppressor Protein p53 Paclitaxel Radiation-Sensitizing Agents Hypertonic Solutions RNA, Small Interfering Camptothecin Fluorouracil Hypotonic Solutions Enzyme Inhibitors Etoposide Cancer Vaccines RNA, Messenger Antimetabolites, Antineoplastic P-Glycoprotein Ellipticines Tumor Markers, Biological Proto-Oncogene Proteins c-bcl-2 Antibodies, Monoclonal Protein Kinase Inhibitors DNA, Neoplasm Anticarcinogenic Agents Caspases Plant Extracts DNA-Binding Proteins Receptor, erbB-2 Antigens, Neoplasm Organoplatinum Compounds Caspase 3 Receptor, Epidermal Growth Factor Prodrugs Tumor Suppressor Proteins DNA Protein-Serine-Threonine Kinases Nanocapsules Platinum Radiation-Protective Agents Deoxycytidine Topoisomerase I Inhibitors Proto-Oncogene Proteins c-akt Taxoids Antineoplastic Agents, Alkylating Water Histone Deacetylase Inhibitors Daunorubicin DNA Topoisomerases, Type II Apoptosis Regulatory Proteins Tamoxifen Potassium Drugs, Investigational Receptors, Estrogen Nuclear Proteins Angiogenesis Inhibitors Proto-Oncogene Proteins Vinblastine Reactive Oxygen Species Cell Cycle Proteins Prostate-Specific Antigen Poly(ADP-ribose) Polymerases TOR Serine-Threonine Kinases Quinazolines Mitomycin Antibodies, Monoclonal, Humanized TNF-Related Apoptosis-Inducing Ligand Antineoplastic Agents, Hormonal Inhibitor of Apoptosis Proteins Liposomes MicroRNAs Indoles Topoisomerase Inhibitors Adjuvants, Pharmaceutic Mitoxantrone DNA Adducts

Analytical, Diagnostic and Therapeutic Techniques and Equipment59

Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Monitoring Models, Biological Early Detection of Cancer Molecular Targeted Therapy Radiotherapy Combined Modality Therapy Drug Carriers Neoplasm Transplantation Antineoplastic Combined Chemotherapy Protocols Clinical Trials as Topic Blotting, Western Drug Design Radiation Injuries, Experimental Transplantation, Heterologous Inhibitory Concentration 50 Radiotherapy Dosage Tumor Burden Reverse Transcriptase Polymerase Chain Reaction Neoplasms, Experimental Radiometry Survival Analysis Prognosis Flow Cytometry Transfection Survival Rate Gene Expression Profiling Drug Evaluation, Preclinical Treatment Outcome Retrospective Studies Genetic Therapy Neoplasm Staging Drug Discovery Follow-Up Studies Nanocapsules Disease-Free Survival Radiotherapy, Adjuvant Hyperthermia, Induced Chemotherapy, Adjuvant Risk Assessment Immunotherapy Prospective Studies Gene Knockdown Techniques Mammary Neoplasms, Experimental Risk Tumor Stem Cell Assay Clinical Trials, Phase I as Topic Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Registries Individualized Medicine Reproducibility of Results Dose Fractionation Disease Models, Animal Immunohistochemistry

Phenomena and Processes56

Radiation, Ionizing Radiation Dosage Dose-Response Relationship, Radiation Radiation Tolerance Apoptosis Drug Resistance, Neoplasm Radiation Cell Survival Gene Expression Regulation, Neoplastic Cell Proliferation Time Factors DNA Damage Cell Cycle Osmosis Gamma Rays Dose-Response Relationship, Drug Signal Transduction Cosmic Radiation Drug Synergism Osmotic Pressure Inhibitory Concentration 50 Cell Division Mutation Drug Resistance, Multiple Cell Size DNA Repair Ultraviolet Rays Down-Regulation Transfection Background Radiation Molecular Structure RNA Interference Cell Death Cell Growth Processes Phosphorylation Algorithms Radiation Effects Up-Regulation Base Sequence Cell Movement Genes, p53 Osmolar Concentration Gene Silencing Gene Expression Risk Genetic Predisposition to Disease Promoter Regions, Genetic Enzyme Activation X-Rays Sensitivity and Specificity Protein Binding DNA Methylation Tumor Microenvironment Structure-Activity Relationship Tissue Distribution DNA Adducts

Disciplines and Occupations7

Radiation Oncology Drug Design Nanomedicine Medical Oncology Drug Discovery Individualized Medicine Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture5

Transportation Nanoparticles Nanomedicine Nanocapsules Liposomes

Information Science6

Survival Rate Algorithms Molecular Sequence Data Base Sequence Computer Simulation Registries

Named Groups1

Health Care27

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Clinical Trials as Topic Radiation Injuries, Experimental Housing, Animal National Cancer Institute (U.S.)Survival Analysis Ultraviolet Rays Survival Rate Treatment Outcome Retrospective Studies Follow-Up Studies Radiation Effects Disease-Free Survival Risk Assessment Prospective Studies Risk Clinical Trials, Phase I as Topic Sensitivity and Specificity Registries Reproducibility of Results Acute Radiation Syndrome Age Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Neoplasms Radiation, Ionizing Radiation Dosage Cell Line, Tumor Radiation Injuries Dose-Response Relationship, Radiation Radiation Tolerance Drug Screening Assays, Antitumor Apoptosis Drug Resistance, Neoplasm Radiation Mice, Nude Cell Survival Radiation Protection Xenograft Model Antitumor Assays Breast Neoplasms Transportation Drug Delivery Systems Radiation Monitoring Pasteurellosis, Pneumonic Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin Gene Expression Regulation, Neoplastic Cell Proliferation Tumor Cells, Cultured Colonic Neoplasms Lung Neoplasms Antibiotics, Antineoplastic Prostatic Neoplasms Models, Biological Early Detection of Cancer Radiation Oncology Time Factors Ovarian Neoplasms Molecular Targeted Therapy Radiotherapy DNA Damage Combined Modality Therapy Drug Carriers Cell Cycle Neoplasm Proteins Tumor Suppressor Protein p53 Neoplasms, Radiation-Induced Neoplasm Transplantation Neoplasm Metastasis Osmosis Gamma Rays Paclitaxel Radiation-Sensitizing Agents Dose-Response Relationship, Drug Hypertonic Solutions Antineoplastic Combined Chemotherapy Protocols Signal Transduction Pancreatic Neoplasms RNA, Small Interfering Stomach Neoplasms Cosmic Radiation Clinical Trials as Topic Neoplasm Invasiveness Drug Synergism Blotting, Western Camptothecin Drug Design Fluorouracil Nanoparticles Osmotic Pressure Radiation Injuries, Experimental Transplantation, Heterologous Hypotonic Solutions Carcinoma, Squamous Cell Inhibitory Concentration 50 Enzyme Inhibitors Nanomedicine Pasteurella Infections Radiation Pneumonitis Radiotherapy Dosage Housing, Animal Etoposide Cancer Vaccines Cell Division Tumor Burden Mutation Reverse Transcriptase Polymerase Chain Reaction Neoplasms, Experimental RNA, Messenger Drug Resistance, Multiple Cell Size National Cancer Institute (U.S.)Neovascularization, Pathologic Carcinoma, Non-Small-Cell Lung Carcinoma DNA Repair HCT116 Cells Antimetabolites, Antineoplastic Adenocarcinoma Radiometry MCF-7 Cells P-Glycoprotein

No FAQ available that match "shrink cancer therapy anticancer drugs or radiation"